Registries have long been an effective tool for gathering data. The data provided through registries generates important insights into patient characteristics and behaviors, standards of care, treatment landscape(s), and long-term clinical outcomes of a pharmaceutical or medical device product.

Recent advances in collecting and leveraging real world data (RWD) to generate real world evidence (RWE) have exponentially increased the value of registries by allowing companies to understand and differentiate their products and development portfolios & tactics.

RWE is evidence on health care that is generated from data derived from multiple sources outside of the typical clinical research setting. It helps provide information that is relevant and meaningful to stakeholders, that often could not be collected from the traditional randomized clinical trial model.

At WEP Clinical, our clinical and commercial teams work together to share best practices, interpretations, and knowledge to ensure the success of your registry. We are committed to working with you to design, develop and deliver registries, that will generate the RWE needed to gain insights and add value to your R&D, early access and/or commercialization efforts.

WEP has the capabilities to assist with your patient registries needs whether they are:

  • Disease-specific registries

  • Drug/treatment-specific registries

By meeting your needs for generating RWE through registries, WEP Clinical will ensure that you have meaningful evidence to support decisions being made by and for the following stakeholders:

  • You (as the sponsor)

  • Physicians and patients

  • Regulatory bodies

  • Health plan providers and reimbursement agencies

If you would like more information on our registry services & capabilities, please contact us using the link below: